BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1035 results:

  • 1. Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in gastric cancer Cells.
    Jung JY; Koh SA; Lee KH
    Anticancer Res; 2024 May; 44(5):1973-1981. PubMed ID: 38677740
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
    Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
    Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis.
    Zhao C; Mu M; Li X; Dong Z; Wang J; Yao C; Zheng J; Sun X; Yu J
    Front Immunol; 2024; 15():1326137. PubMed ID: 38469295
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Xianglian Pill combined with 5-fluorouracil enhances antitumor activity and reduces gastrointestinal toxicity in gastric cancer by regulating the p38 MAPK/NF-κB signaling pathway.
    Yu L; Qin JY; Sun C; Peng F; Chen Y; Wang SJ; Tang J; Lin ZW; Wu LJ; Li J; Cao XY; Li WQ; Xie XF; Peng C
    J Ethnopharmacol; 2024 May; 326():117988. PubMed ID: 38428657
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
    Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
    Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anticancer Effects of
    Han EJ; Choi EY; Jeon SJ; Moon JM; Lee SW; Lee JH; Jung GH; Han SH; Jung SH; Yang MS; Jung JY
    J Med Food; 2024 Apr; 27(4):330-338. PubMed ID: 38387002
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the erk1/2 and JAK/STAT pathways.
    Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
    Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.
    Peng Y; Lei X; Yang Q; Zhang G; He S; Wang M; Ling R; Zheng B; He J; Chen X; Li F; Zhou Q; Zhao L; Ye G; Li G
    Exp Mol Med; 2024 Feb; 56(2):441-452. PubMed ID: 38383581
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Homeobox Protein BarH-like 1 Promotes gastric cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
    Gu Y; Chen G; Ning X
    Dig Dis Sci; 2024 Apr; 69(4):1182-1199. PubMed ID: 38358459
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
    Hosseini SA; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
    Epigenomics; 2024 Mar; 16(5):277-292. PubMed ID: 38356395
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells.
    Su BC; Chen GY; Yang CM; Chuang WT; Lin MC; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Yu HH
    Int J Hyperthermia; 2024; 41(1):2310017. PubMed ID: 38350654
    [No Abstract]    [Full Text] [Related]  

  • 12. Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways.
    Liu J; Li SM; Tang YJ; Cao JL; Hou WS; Wang AQ; Wang C; Jin CH
    Redox Rep; 2024 Dec; 29(1):2313366. PubMed ID: 38318818
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
    Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
    Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.
    Che K; Luo Y; Song X; Yang Z; Wang H; Shi T; Wang Y; Wang X; Wu H; Yu L; Liu B; Wei J
    EMBO Mol Med; 2024 Feb; 16(2):251-266. PubMed ID: 38238529
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
    Weng J; Wu XF; Shao P; Liu XP; Wang CX
    Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts.
    Choi KM; Kim B; Lee SM; Han J; Bae HS; Han SB; Lee D; Ham IH; Hur H; Kim E; Kim JY
    Cell Commun Signal; 2024 Jan; 22(1):8. PubMed ID: 38167009
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Loss of keratin 23 enhances growth inhibitory effect of melatonin in gastric cancer.
    Li L; Lin M; Luo J; Sun H; Zhang Z; Lin D; Chen L; Feng S; Lin X; Zhou R; Song J
    Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38099343
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in gastric cancer Through the NF-κB Pathway.
    Lou M; Iwatsuki M; Wu X; Zhang W; Matsumoto C; Baba H
    Ann Surg Oncol; 2024 May; 31(5):2983-2995. PubMed ID: 38006530
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Investigating the therapeutic mechanism of Xiaotan Sanjie Formula for gastric cancer via network pharmacology and molecular docking: A review.
    Xu X; Yu Z; Zeng S
    Medicine (Baltimore); 2023 Nov; 102(46):e35986. PubMed ID: 37986339
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulatory roles of ACSL5 in the anti-tumor function of palmitic acid (C16:0) via the erk signaling pathway.
    Lv J; Yanting W; Wei S
    Eur J Histochem; 2023 Nov; 67(4):. PubMed ID: 37946526
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 52.